OCS Liver PROTECT Continuation Post-Approval Study

Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Transplant

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of California San Diego, La Jolla, California, United States

About this study

Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects transplanted in the OCS Liver PROTECT Trial

Treatment and study plan

OCS Liver

Device

Transplanted with a OCS preserved liver

Primary outcomes

Liver Graft Survival

Time frame: 2 years

Liver Graft Survival through 2 years (24 months) after transplantation.

Other outcomes

Patient Survival

Time frame: 2 years

Patient Survival (freedom from mortality) through 2 years (24 months) after transplantation.

Sponsors and collaborators

Lead sponsor

TransMedics

Industry

Registry information

Important dates

Study start: 2016
Primary completion: 2021
Study completion: 2021
First posted: Oct 27, 2021
Registry last updated: Jan 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed